First Time Loading...

Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 3.56 USD -3.52% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. [ Read More ]

The intrinsic value of one HBIO stock under the Base Case scenario is 5.76 USD. Compared to the current market price of 3.56 USD, Harvard Bioscience Inc is Undervalued by 38%.

Key Points:
HBIO Intrinsic Value
Base Case
5.76 USD
Undervaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Harvard Bioscience Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HBIO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Harvard Bioscience Inc

Provide an overview of the primary business activities
of Harvard Bioscience Inc.

What unique competitive advantages
does Harvard Bioscience Inc hold over its rivals?

What risks and challenges
does Harvard Bioscience Inc face in the near future?

Has there been any significant insider trading activity
in Harvard Bioscience Inc recently?

Summarize the latest earnings call
of Harvard Bioscience Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Harvard Bioscience Inc.

Provide P/S
for Harvard Bioscience Inc.

Provide P/E
for Harvard Bioscience Inc.

Provide P/OCF
for Harvard Bioscience Inc.

Provide P/FCFE
for Harvard Bioscience Inc.

Provide P/B
for Harvard Bioscience Inc.

Provide EV/S
for Harvard Bioscience Inc.

Provide EV/GP
for Harvard Bioscience Inc.

Provide EV/EBITDA
for Harvard Bioscience Inc.

Provide EV/EBIT
for Harvard Bioscience Inc.

Provide EV/OCF
for Harvard Bioscience Inc.

Provide EV/FCFF
for Harvard Bioscience Inc.

Provide EV/IC
for Harvard Bioscience Inc.

Show me price targets
for Harvard Bioscience Inc made by professional analysts.

What are the Revenue projections
for Harvard Bioscience Inc?

How accurate were the past Revenue estimates
for Harvard Bioscience Inc?

What are the Net Income projections
for Harvard Bioscience Inc?

How accurate were the past Net Income estimates
for Harvard Bioscience Inc?

What are the EPS projections
for Harvard Bioscience Inc?

How accurate were the past EPS estimates
for Harvard Bioscience Inc?

What are the EBIT projections
for Harvard Bioscience Inc?

How accurate were the past EBIT estimates
for Harvard Bioscience Inc?

Compare the revenue forecasts
for Harvard Bioscience Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Harvard Bioscience Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Harvard Bioscience Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Harvard Bioscience Inc compared to its peers.

Compare the P/E ratios
of Harvard Bioscience Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Harvard Bioscience Inc with its peers.

Analyze the financial leverage
of Harvard Bioscience Inc compared to its main competitors.

Show all profitability ratios
for Harvard Bioscience Inc.

Provide ROE
for Harvard Bioscience Inc.

Provide ROA
for Harvard Bioscience Inc.

Provide ROIC
for Harvard Bioscience Inc.

Provide ROCE
for Harvard Bioscience Inc.

Provide Gross Margin
for Harvard Bioscience Inc.

Provide Operating Margin
for Harvard Bioscience Inc.

Provide Net Margin
for Harvard Bioscience Inc.

Provide FCF Margin
for Harvard Bioscience Inc.

Show all solvency ratios
for Harvard Bioscience Inc.

Provide D/E Ratio
for Harvard Bioscience Inc.

Provide D/A Ratio
for Harvard Bioscience Inc.

Provide Interest Coverage Ratio
for Harvard Bioscience Inc.

Provide Altman Z-Score Ratio
for Harvard Bioscience Inc.

Provide Quick Ratio
for Harvard Bioscience Inc.

Provide Current Ratio
for Harvard Bioscience Inc.

Provide Cash Ratio
for Harvard Bioscience Inc.

What is the historical Revenue growth
over the last 5 years for Harvard Bioscience Inc?

What is the historical Net Income growth
over the last 5 years for Harvard Bioscience Inc?

What is the current Free Cash Flow
of Harvard Bioscience Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Harvard Bioscience Inc.

Financials

Balance Sheet Decomposition
Harvard Bioscience Inc

Current Assets 49m
Cash & Short-Term Investments 4.3m
Receivables 20m
Other Current Assets 24.7m
Non-Current Assets 88.3m
PP&E 8.8m
Intangibles 73.1m
Other Non-Current Assets 6.5m
Current Liabilities 26.5m
Accounts Payable 5.6m
Accrued Liabilities 9.4m
Other Current Liabilities 11.6m
Non-Current Liabilities 37.8m
Long-Term Debt 30.7m
Other Non-Current Liabilities 7m
Efficiency

Earnings Waterfall
Harvard Bioscience Inc

Revenue
112.3m USD
Cost of Revenue
-45.9m USD
Gross Profit
66.4m USD
Operating Expenses
-64.1m USD
Operating Income
2.3m USD
Other Expenses
-5.7m USD
Net Income
-3.4m USD

Free Cash Flow Analysis
Harvard Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

HBIO Profitability Score
Profitability Due Diligence

Harvard Bioscience Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive Free Cash Flow
Positive 3-Years Revenue Growth
44/100
Profitability
Score

Harvard Bioscience Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

HBIO Solvency Score
Solvency Due Diligence

Harvard Bioscience Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
39/100
Solvency
Score

Harvard Bioscience Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HBIO Price Targets Summary
Harvard Bioscience Inc

Wall Street analysts forecast HBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HBIO is 7.06 USD with a low forecast of 6.82 USD and a high forecast of 7.35 USD.

Lowest
Price Target
6.82 USD
92% Upside
Average
Price Target
7.06 USD
98% Upside
Highest
Price Target
7.35 USD
106% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

HBIO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

HBIO Price
Harvard Bioscience Inc

1M 1M
-11%
6M 6M
-18%
1Y 1Y
-36%
3Y 3Y
-49%
5Y 5Y
-8%
10Y 10Y
-20%
Annual Price Range
3.56
52w Low
3.56
52w High
6.16
Price Metrics
Average Annual Return 6.08%
Standard Deviation of Annual Returns 59%
Max Drawdown -75%
Shares Statistics
Market Capitalization 154.5m USD
Shares Outstanding 43 421 300
Percentage of Shares Shorted 1.58%

HBIO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Harvard Bioscience Inc Logo
Harvard Bioscience Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

154.5m USD

Dividend Yield

0%

Description

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 475 full-time employees. The company went IPO on 2013-10-21. The firm provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms or preclinical, and clinical. The firm organizes its product line activities into two product families, Cellular and Molecular Technologies (CMT) and Preclinical. The company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The firm's customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.

Contact

MASSACHUSETTS
Holliston
84 October Hill Rd
+15088938999.0
https://www.harvardbioscience.com/

IPO

2013-10-21

Employees

475

Officers

President, CEO & Chairman
Mr. James W. Green
CFO & Treasurer
Ms. Jennifer Cote CPA, CGMA
Senior Vice President of Operations
Mr. David Balcom
Chief Legal Counsel & Corporation Secretary
Mr. John J. Fry
Senior Vice President of Global Sales
Mr. Ryan Wallace
Vice President of Global People Operations
Ms. Lori Packer
Show More
Director of Corporate Accounting & SEC Reporting
David Sirois
Show Less

See Also

Discover More
What is the Intrinsic Value of one HBIO stock?

The intrinsic value of one HBIO stock under the Base Case scenario is 5.76 USD.

Is HBIO stock undervalued or overvalued?

Compared to the current market price of 3.56 USD, Harvard Bioscience Inc is Undervalued by 38%.